Pain Management

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

Dive in and learn more about the answers to yesterday’s quiz.

Test your knowledge different headache types.

Check out this list of resources to share with patients who are managing a migraine or other headache diagnosis.

The agency issued warning letters to 6 companies manufacturing these products.

The average US household spent $645 on OTC products in 2022.

Telehealth mitigates barriers like stigma, fear, and legal concerns associated with receiving opioid use disorder (OUD) care by offering a convenient and discreet treatment option.

With growing concerns around opioid use disorder, interventional pain management for patients with cancer can provide effective relief without the side effects associated with medication.

Complementary health approaches, like yoga or acupuncture, can be particularly appealing to patients seeking natural and non-invasive approaches to improve their health.

These populations are also more likely to receive opioid analgesic therapies.

The CDC first released opioid prescribing guidelines in 2016.

A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.

Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.

Despite societal need, stigma around MAT and MOUD still exists.

Despite a wealth of data proving their efficacy for acute and chronic pain, these products remain underutilized in the United States.

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

Filling a prescription for a controlled substance requires more oversight than the average prescription.

Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.

The alert was implemented after passage of a state senate bill.

Study results add to the body of evidence demonstrating the efficacy of CGRP inhibitors for migraine treatment and prophylaxis.

This treatment is the first and only long-acting buprenorphine injectable with weekly and monthly doses.

A new meta-analysis found duloxetine to be the only commonly prescribed medication that was effective.

Only the 60 mg dose of atogepant is approved for chronic migraine prevention.